There are multiple techniques for performing liver biopsies via a celiotomy. Ultimately, the choice of technique is at the ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Cirrhosis can cause scar tissue to gradually replace healthy liver cells. In time, this can affect liver function and lead to hair, skin, and nail symptoms such as rashes and discoloration.

Michael Tadros, MD, MPH, discusses how lessons learned from HCV treatment could improve the management of metabolic ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

Researchers have discovered in a new study that abnormal serum thyroid hormone levels are independently correlated with a ...

It is the first approved medication for the treatment of MASH in the U.S. In the pivotal Phase 3 MAESTRO-NASH biopsy ... is a serious liver disease that can progress to cirrhosis, liver failure ...

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced six ...